AARTI PHARMALABS
Back to Cashflow Statement
|
AARTI PHARMALABS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-17 Cr | ₹12 Cr | ₹-71 Cr | ₹78 Cr | - |
What is the latest Net Cash Inflow / Outflow ratio of AARTI PHARMALABS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-17 Cr |
| Mar2024 | ₹12 Cr |
| Mar2023 | ₹-71 Cr |
| Mar2022 | ₹78 Cr |
| Mar2021 | - |
How is Net Cash Inflow / Outflow of AARTI PHARMALABS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-17 Cr | Negative | |
| Mar2024 | ₹12 Cr | Positive | |
| Mar2023 | ₹-71 Cr | Negative | |
| Mar2022 | ₹78 Cr | 0 | |
| Mar2021 | - | - | |
Compare Net Cash Inflow / Outflow of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹6,271.9 Cr | 0% | -0.6% | -15.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,792.0 Cr | 1.4% | 1.2% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,152.0 Cr | -0.5% | -0.6% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,915.0 Cr | 2.1% | 1.5% | 42.2% | Stock Analytics | |
| CIPLA | ₹116,354.0 Cr | 6.4% | 1.6% | -3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,681.0 Cr | 6.2% | 1.6% | 0.2% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | 0% |
-0.6% |
-15.5% |
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses